NPIP is the UK’s first-of-its-kind national total-body PET imaging platform for drug discovery research.
With an investment of £32 million from the UK Government through UK Research and Innovation (UKRI), NPIP's ground breaking total-body PET technology platform will help drive the nation's reputation as a global life science superpower.
The investment has funded a unique blend of high-tech infrastructure and collective intelligence, all delivered through the National PET Imaging Platform (NPIP). Through NPIP, the nation will have a richer picture of human health for clinical research, helping us to develop drugs and diagnostics more effectively and bring them to market quicker.
Two cutting-edge total-body PET scanners, provided by Siemens Healthineers, will deliver outstanding image clarity of a patient’s entire body in near real-time. These state-of-the-art facilities will be sited in Scotland and London and will serve the length and breadth of the UK. Each location will be jointly managed by the Universities of Edinburgh and Glasgow in Scotland and by Imperial College London and King’s College London.
Opportunities
Total-body PET scanning is a crucial, non-invasive imaging technique that can detect the early onset of disease.
Total-body PET scans are quicker than conventional PET scans and capture the entire body’s activity with greater accuracy, precision and detail, facilitating more patient scans and enabling a much wider application than ever before. Patients of total-body PET are also exposed to considerably lower doses of radiation, meaning that more patients can now participate in clinical trials to improve researchers’ understanding of diseases.
Learn more
Meet the NPIP Team
Dr Phil Murphy
Executive Chair
As NPIP Executive Chair, Dr Phil Murphy will help set a strategic vision for NPIP through strong engagement within the UK PET community and internationally.
Dr Juliana Maynard
Director of Operations & Engagement
As Director of Operations and Engagement, Dr Juliana Maynard will oversee the overall delivery of NPIP goals and objectives to ensure the platform is fully utilised.
Dr Ian Wilson
PET Engagement & Delivery Manager
As PET Engagement & Delivery Manager, Dr Ian Wilson will strategically build and grow collaborative opportunities across the platform.
Our Partners
This new platform represents a huge step forward for clinical research, enabling more patients to take part in clinical trials, delivering more scans, and enhancing our understanding of diseases. Ultimately this could help lead to the development of new drugs and treatments to tackle some of the biggest health challenges of our time, from cancer to dementia.
Backed by £32 million through the UK Research and Innovation Infrastructure Fund, this demonstrates once again the UK’s commitment to investing in cutting-edge technology to boost research and cement our reputation as a life sciences superpower.
Join the Platform
NPIP is a collaboration platform that enables everyone working in medical research and drug discovery to innovate across boundaries.
Join the Platform